IL17A and myeloid sarcoma: Previous research has shown that IL-17A levels are elevated in the cerebrospinal fluid of MS patients compared to controls [76,77], along with an increased frequency of IL-17A-producing T cells [78,79,80], and the presence of IL-17A-producing cells in the CNS [69,74,81].